Skip to content
Screener

Scholar Rock SRRK Total Revenue

Total Revenue at other companies

Biogen logo
BiogenBIIB
$2.74B+3.4%
PTC Therapeutics logo
PTC TherapeuticsPTCT
$272.55M-76.8%
Solid Biosciences Inc. logo
Solid Biosciences Inc.SLDB
$2.02M-40.6%
CalAmp logo
CalAmpCAMP
$1.29M+50.8%
Wave Life Sciences logo
Wave Life SciencesWVE
$2.27M-73.9%

Other financials

Income statement

See full
Operating income-$108.9M+2.9%
Net income-$109.9M+0.1%
EPS (diluted)-$0.84+14.3%

Balance sheet

See full
Cash & equivalents$437.1M+186%
Total debt$203.8M+231%
Total equity$253.8M+8.8%
Total assets$523.5M+54.0%

Cash flow

See full
Operating cash flow-$70.3M+8.6%
CapEx$1.0K-99.5%
Free cash flow-$70.3M+8.9%

Valuation

See full
Market cap$5.74B+92.7%
Enterprise value$5.5B+90.9%

Profitability

See full
Operating margin-231.8%—
Net margin-236.9%—
FCF margin-309.1%—

Returns & leverage

See full
Return on equity-167.8%-4.1pp
Debt / equity0.8×+0.5×
Current ratio7×+0.7×

Where this comes from

Reported directly by Scholar Rock in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The source filing: Scholar Rock’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 7:20 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-336732

Revenue generation activities have been limited to two collaborations, both containing research services and the issuance of a license. No revenues have been recorded from the sale of any commercial product.

Item 1. Financial Statements

FAQ

What is Scholar Rock's total revenue?
Scholar Rock (SRRK) reported total revenue of $0 in Q2 2026.
What does total revenue mean?
The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.

Ask your AI about Scholar Rock's total revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude